Efimia Papadopoulou-Alataki
Overview
Explore the profile of Efimia Papadopoulou-Alataki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lampidi S, Maritsi D, Charakida M, Eleftheriou I, Farmaki E, Spyridis N, et al.
Eur J Pediatr
. 2024 Jan;
183(4):1693-1702.
PMID: 38214810
Conclusion: MIS-C is a novel, infrequent but serious disease entity. Cardiac manifestations included myocarditis and pericarditis, which resolved in most patients before discharge. Timely initiation of immunomodulatory therapy was shown...
2.
Eleftheriou I, Maritsi D, Lampidi S, Charisi K, Vantsi P, Skourti K, et al.
Pediatr Infect Dis J
. 2023 Jan;
42(2):122-124.
PMID: 36638397
In this nationwide retrospective study, a substantial decline in the incidence of multisystem inflammatory syndrome in children over 3 successive pandemic waves characterized by different severe acute respiratory syndrome coronavirus...
3.
Bustaffa M, Kone-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, et al.
Semin Arthritis Rheum
. 2022 Nov;
58:152123.
PMID: 36404149
No abstract available.
4.
Gavriilaki E, Tsiftsoglou S, Touloumenidou T, Farmaki E, Panagopoulou P, Michailidou E, et al.
Curr Issues Mol Biol
. 2022 Jul;
44(7):2811-2824.
PMID: 35877417
Complement dysregulation has been documented in adults with COVID-19 and implicated in relevant pediatric inflammatory responses against SARS-CoV-2. We propose that signatures of complement missense coding SNPs associated with dysregulation...
5.
Papadopoulou-Legbelou K, Triantafyllou A, Vampertzi O, Koletsos N, Douma S, Papadopoulou-Alataki E
Pulse (Basel)
. 2022 Jan;
9(3-4):64-71.
PMID: 35083172
Background And Aims: This study investigated the possible correlation between elevated lipoprotein (a) (Lp(a)) levels and early vascular aging biomarkers in healthy children and adolescents. Methods: Twenty-seven healthy children/adolescents, mean...
6.
Bustaffa M, Kone-Paut I, Ozen S, Amaryan G, Papadopoulou-Alataki E, Gallizzi R, et al.
Semin Arthritis Rheum
. 2022 Jan;
52:151957.
PMID: 35042149
Introduction: New Eurofever/PRINTO classification criteria (EPCC) for Familial Mediterranean Fever (FMF) and other recurrent fevers have been recently developed, together with the classification of the pathogenicity of MEFV variants. Objectives:...
7.
Vampertzi O, Papadopoulou-Legbelou K, Triantafyllou A, Koletsos N, Alataki S, Douma S, et al.
Rheumatol Int
. 2021 Nov;
42(1):59-69.
PMID: 34739572
Familial Mediterranean Fever (FMF) is the most frequent autoinflammatory disease. This study aimed to evaluate the risk of subclinical vascular damage in FMF children, and young adults, using both imaging...
8.
Karananou P, Alataki A, Papadopoulou-Alataki E
Case Reports Immunol
. 2020 Oct;
2020:8846827.
PMID: 33101742
Background: Human interleukin- (IL-) 1 receptor-associated kinase 4 (IRAK-4) deficiency is a recently described primary immunodeficiency. It is a rare, autosomal recessive immunodeficiency that impairs toll/IL-1R immunity, except for the...
9.
Vampertzi O, Papadopoulou-Legbelou K, Triantafyllou A, Douma S, Papadopoulou-Alataki E
Rheumatol Int
. 2019 Nov;
40(1):1-8.
PMID: 31705200
Familial Mediterranean fever is a chronic inflammatory disease characterized by periodic and self-limited episodes of fever and aseptic polyserositis. Although colchicine treatment has altered the course of the disease, it...
10.
Papadopoulou-Alataki E, Dogantzis P, Chatziavramidis A, Alataki S, Karananou P, Chiona K, et al.
Int J Inflam
. 2019 Oct;
2019:7278907.
PMID: 31662845
Juvenile recurrent parotitis (JRP) is a recurrent parotid inflammation of nonobstructive, nonsuppurative nature. It manifests in childhood and usually resolves after puberty but may also persist into adulthood. JRP is...